These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 33157550

  • 1. Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.
    Tran PN, Sheng J, Randolph AL, Baron CA, Thiebaud N, Ren M, Wu M, Johannesen L, Volpe DA, Patel D, Blinova K, Strauss DG, Wu WW.
    PLoS One; 2020; 15(11):e0241362. PubMed ID: 33157550
    [Abstract] [Full Text] [Related]

  • 2. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro.
    Fanoe S, Jensen GB, Sjøgren P, Korsgaard MP, Grunnet M.
    Br J Clin Pharmacol; 2009 Feb; 67(2):172-9. PubMed ID: 19159406
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C, Pierre-Valentin J, Pollard C, Standen N, Mitcheson J, Alexander P, Thong B.
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
    Jehle J, Ficker E, Wan X, Deschenes I, Kisselbach J, Wiedmann F, Staudacher I, Schmidt C, Schweizer PA, Becker R, Katus HA, Thomas D.
    Br J Pharmacol; 2013 Mar; 168(5):1215-29. PubMed ID: 23061993
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Electrophysiological evaluation of pentamidine and 17-AAG in human stem cell-derived cardiomyocytes for safety assessment.
    Asahi Y, Nomura F, Abe Y, Doi M, Sakakura T, Takasuna K, Yasuda K.
    Eur J Pharmacol; 2019 Jan 05; 842():221-230. PubMed ID: 30391349
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells.
    De Waard S, Montnach J, Ribeiro B, Nicolas S, Forest V, Charpentier F, Mangoni ME, Gaborit N, Ronjat M, Loussouarn G, Lemarchand P, De Waard M.
    Int J Mol Sci; 2020 Sep 28; 21(19):. PubMed ID: 32998413
    [Abstract] [Full Text] [Related]

  • 13. Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone.
    Bartko TM, Lutgen SM, Ross RA, Walisser JA, Garske EP, Kopelke KR, Ashcroft-Hawley K, Tang HM, Kremer JJ, Friedrichs GS, Nichols JV.
    J Pharmacol Toxicol Methods; 2024 Sep 28; 128():107527. PubMed ID: 38852685
    [Abstract] [Full Text] [Related]

  • 14. Intracellular Mechanism of Rosuvastatin-Induced Decrease in Mature hERG Protein Expression on Membrane.
    Feng PF, Zhang B, Zhao L, Fang Q, Liu Y, Wang JN, Xu XQ, Xue H, Li Y, Yan CC, Zhao X, Li BX.
    Mol Pharm; 2019 Apr 01; 16(4):1477-1488. PubMed ID: 30807184
    [Abstract] [Full Text] [Related]

  • 15. Potent hERG channel inhibition by sarizotan, an investigative treatment for Rett Syndrome.
    Cheng H, Du C, Zhang Y, James AF, Dempsey CE, Abdala AP, Hancox JC.
    J Mol Cell Cardiol; 2019 Oct 01; 135():22-30. PubMed ID: 31362019
    [Abstract] [Full Text] [Related]

  • 16. Blockade of the Human Ether A-Go-Go-Related Gene (hERG) Potassium Channel by Fentanyl.
    Tschirhart JN, Li W, Guo J, Zhang S.
    Mol Pharmacol; 2019 Apr 01; 95(4):386-397. PubMed ID: 30665971
    [Abstract] [Full Text] [Related]

  • 17. Opioids-induced inhibition of HERG ion channels and sudden cardiac death, a systematic review of current literature.
    El Sherbini A, Liblik K, Lee J, Baranchuk A, Zhang S, El-Diasty M.
    Trends Cardiovasc Med; 2024 Jul 01; 34(5):279-285. PubMed ID: 37015297
    [Abstract] [Full Text] [Related]

  • 18. BeKm-1, a peptide inhibitor of human ether-a-go-go-related gene potassium currents, prolongs QTc intervals in isolated rabbit heart.
    Qu Y, Fang M, Gao B, Chui RW, Vargas HM.
    J Pharmacol Exp Ther; 2011 Apr 01; 337(1):2-8. PubMed ID: 21205913
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias.
    Blinova K, Stohlman J, Vicente J, Chan D, Johannesen L, Hortigon-Vinagre MP, Zamora V, Smith G, Crumb WJ, Pang L, Lyn-Cook B, Ross J, Brock M, Chvatal S, Millard D, Galeotti L, Stockbridge N, Strauss DG.
    Toxicol Sci; 2017 Jan 01; 155(1):234-247. PubMed ID: 27701120
    [Abstract] [Full Text] [Related]

  • 20. Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.
    Yue Y, Castrichini M, Srivastava U, Fabris F, Shah K, Li Z, Qu Y, El-Sherif N, Zhou Z, January C, Hussain MM, Jiang XC, Sobie EA, Wahren-Herlenius M, Chahine M, Capecchi PL, Laghi-Pasini F, Lazzerini PE, Boutjdir M.
    Circulation; 2015 Jul 28; 132(4):230-40. PubMed ID: 25995318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.